ALTEOGEN Market Cap

ALTEOGEN has a market cap or net worth of 25.22 trillion as of October 6, 2025. Its market cap has increased by 54.36% in one year.

Market Cap

25.22T

Enterprise Value

24.96T

Revenue

158.06B

Ranking

n/a

PE Ratio

291.53

Stock Price

471,500.00

Market Cap Chart

Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 25.22T, an increase of 20,921.77%. That is a compound annual growth rate of 63.98%.

Market Cap History

Date	Market Cap	% Change
Oct 2, 2025	25.22T	52.88%
Dec 30, 2024	16.49T	221.05%
Dec 28, 2023	5,137.84B	160.78%
Dec 29, 2022	1,970.17B	-38.41%
Dec 30, 2021	3,198.72B	-36.62%
Dec 30, 2020	5,046.50B	442.81%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.81T
Celltrion	38.64T
Yuhan	8,969.60B
SK Biopharmaceuticals	8,144.58B
Peptron	7,006.86B
PharmaResearch	5,714.31B
LigaChem Biosciences	5,545.53B
ABL Bio	5,258.94B

Market Cap Rankings